Benjamin Mizukawa
Research Director · Cincinnati Children's Hospital Medical Center
Credentials: · · · ·
History
Research
Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells
Journal of Clinical Investigation · 2013 · 173 citations
British Journal of Haematology · 2017 · 116 citations
AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
Blood · 2013 · 98 citations
7 papers
5 papers
5 papers
5 papers
4 papers · 1 as a fellow
4 papers
4 papers
3 papers
Clinical trials
- 2026–2033
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
- 2025–2028
Sub-investigator · Recruiting · Phase 2
Healx Limited